SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as traders speculate about upcoming Phase 3 HOPE-3 data for DMD, which is expected to be a major catalyst. Community members are discussing potential leaks, short squeezes, and the impact of the data on the company's future, with some expressing concerns about short positions. Many believe positive results could send the stock soaring, while others remain cautious.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The crypto, crow with knife ($CAW), is gaining attention, with the community highlighting its multichain functionality and burn mechanisms. There's enthusiasm around the project's organic growth and strong community, often referred to as the 'caWmunity'. Bullish sentiment is expressed with 'caw caw' and references to potential gains within the Solana ecosystem.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending due to positive buzz around its AWS re:Invent conference, particularly excitement for new AI chips and services like Trainium3 and Nova AI. The community is actively discussing the potential impact on AI infrastructure and Amazon's competition with Nvidia and Google in the AI space. There's also some discussion around Anthropic's potential IPO and Amazon's involvement.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is trending as investors discuss its potential following a surge in robotaxi revenue and increased institutional interest, including recent share purchases by ARK Invest and a Buy rating from Bank of America. Community members are highlighting the company's global expansion, particularly the launch of fully driverless robotaxi services in Abu Dhabi through Uber. Discussions also involve comparing WeRide's technology and market strategy with competitors like Pony.ai, and anticipating further catalysts by year-end.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is trending amid discussions around the potential extension of Affordable Care Act subsidies, with community members weighing the implications of Republican strategies and potential healthcare policy changes. Bullish sentiment appears unified around expectations of upward price movement, while others express concerns about the company's long-term prospects and potential market volatility. Technical analysis suggests a battleground, with key levels to watch for both bulls and bears as the market reacts to news and speculation.

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Polyrizon Ltd.

Polyrizon Ltd. Ordinary Shares

PLRZ is experiencing significant volatility, driven by news of a manufacturing milestone for its nasal spray product. Community chatter revolves around potential short squeezes and dilution concerns, as the stock demonstrates wild price swings and halts. Traders are actively discussing entry and exit points, with some anticipating a multi-day run while others foresee a sharp decline.

American Eagle Outfitters, Inc. is a multi-brand specialty retailer, which offers an assortment of apparel and accessories for men and women under the American Eagle Outfitters brand, and intimates, apparel and personal care products for women under the Aerie brand. The firm operates stores in the United States, Canada, Mexico, Hong Kong, China and the United Kingdom. It also acquired two emerging brands to complement its existing brands, Tailgate, a vintage sports-inspired apparel brand, and Todd Snyder New York, a premium menswear brand. The company was founded in 1977 and is headquartered in Pittsburgh, PA.

American Eagle Outfitters Inc.

American Eagle Outfitters, Inc.

American Eagle Outfitters is trending after reporting a Q3 earnings beat, driven by strong comparable sales growth and successful marketing campaigns featuring celebrities like Sydney Sweeney. The community is focused on the company's raised Q4 operating income guidance and potential for continued growth during the holiday season. Some traders are wary of the stock being overbought, while others believe it has strong momentum and could reach new highs.

Sailana Inu, the sister of legendary Saitama Inu, is bringing back the Wolfpack and OG community vibes that previously sent Saitama to a $7 billion marketcap in 2021. The power of community mixed with great leadership is what will take this project to great heights. Join the movement, join the pack, become apart of the Sailana Army . Together, we will create something that will go down in history, and something that will be talked about years from now.

Sailana Inu

Sailana Inu is trending as its community, the Wolfpack, expresses strong conviction and dedication to the project. Discussions highlight the community's active role in building and shilling the coin, with some drawing comparisons to early Shiba Inu. The upcoming WolfSWAP, supporting over 20 chains, is also generating excitement.

Gitlab, Inc. provides code hosting and collaboration platform services. It offers continuous integration, source code management, out-of-the-box pipelines, agile development, and value stream management. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in Dover, DE.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

GitLab is trending amidst discussions of a potential acquisition by Datadog, reportedly at a price over $60 per share, though neither company has confirmed the takeover.  The community is weighing the potential deal, with some analysts expressing skepticism, and debating whether GitLab is undervalued, with some suggesting the stock should be worth significantly more. Despite the unconfirmed rumors, GitLab's strong revenue growth and AI integration remain key points of discussion.

A10 Networks, Inc. engages in the provision of networking solutions. It offers security, hybrid cloud, service providers, vertical solutions, and mobile carriers. It operates through the following geographical segments: Americas, Asia-Pacific and Japan (APJ), and Europe, the Middle East, and Africa (EMEA). The Americas segment includes all other countries in the Americas, excluding the Unites States. The APJ segment is involved in all countries in the Asia Pacific region including Japan. The company was founded by Lee Chen in 2004 and is headquartered in San Jose, CA.

A10 Networks Inc

A10 Networks is trending as traders discuss its potential for a short squeeze, highlighting its low PE ratio, net cash position, and recent partnership with Microsoft Azure for AI infrastructure security. Community members are pointing to the company's buyback program, dividend, and margin expansion as factors limiting downside risk, while the Microsoft deal is seen as a clear growth driver. Options traders are also active, with multiple profitable options alerts circulating.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases. Oyster Point Pharmaâ??s lead product candidate, OC-01, a highly selective nicotinic acetylcholine receptor (nAChR) agonist, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. Dry eye disease is a chronic, progressive condition that impacts more than 30 million Americans and is growing in prevalence. OC-01â??s novel mechanism of action re-establishes tear film homeostasis by activating the trigeminal parasympathetic pathway to stimulate the glands and cells responsible for natural tear film production, known as the Lacrimal Functional Unit (LFU).

OYST
Oyster Point Pharma Inc

Feed

News

Sentiment

Fundamentals

Info

Latest OYST News

OYSTOyster Point Pharma Inc